Русский

Pharmaceutical Industry Information Portal

HomeTagsSK Bioscience

All posts by tag

SK Bioscience

SK Bioscience logoSK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.

Discovery and Development

SK bioscience has reached the final stage of development of Korea’s first COVID-19 vaccine

Techno -
SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic...
World Pharma News

First experimental SK Bioscience’s COVID-19 vaccine in South Korea

Techno -
South Korea's state health center has signed a pre-purchase contract for 10 million doses of a COVID-19 vaccine candidate codenamed GBP510 being developed by...
World Pharma News

SK Bioscience to invest $132 million to beef up vaccine production capacity

Techno -
SK Bioscience said the investment is meant to increase the production capacity of the production line based in Andong, about 270 kilometers south of Seoul.
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories